Advertisement

Index by author

January 01, 2006; Volume 34,Issue 1

A

  1. Aninat, Caroline

    1. EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
      Caroline Aninat, Amélie Piton, Denise Glaise, Typhen Le Charpentier, Sophie Langouët, Fabrice Morel, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition January 2006, 34 (1) 75-83; DOI: https://doi.org/10.1124/dmd.105.006759

  2. Aouabdi, Sihem

    1. TRANSCRIPTIONAL REGULATION OF THE PXR GENE: IDENTIFICATION AND CHARACTERIZATION OF A FUNCTIONAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α BINDING SITE WITHIN THE PROXIMAL PROMOTER OF PXR
      Sihem Aouabdi, Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition January 2006, 34 (1) 138-144; DOI: https://doi.org/10.1124/dmd.105.006064

  3. Arcand, Mathieu

    1. MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6
      Oksana Kourylko, Caroline Fradette, Mathieu Arcand and Patrick du Souich
      Drug Metabolism and Disposition January 2006, 34 (1) 27-35; DOI: https://doi.org/10.1124/dmd.105.006528

B

  1. Baillie, Thomas A.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  2. Barone, Gary W.

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

  3. Blobaum, Anna L.

    1. MECHANISM-BASED INACTIVATION AND REVERSIBILITY: IS THERE A NEW TREND IN THE INACTIVATION OF CYTOCHROME P450 ENZYMES?
      Anna L. Blobaum
      Drug Metabolism and Disposition January 2006, 34 (1) 1-7; DOI: https://doi.org/10.1124/dmd.105.004747

  4. Bose, Mousumi

    1. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
      Joshua D. Lambert, Mao-Jung Lee, Lauren Diamond, Jihyeung Ju, Jungil Hong, Mousumi Bose, Harold L. Newmark and Chung S. Yang
      Drug Metabolism and Disposition January 2006, 34 (1) 8-11; DOI: https://doi.org/10.1124/dmd.104.003434

  5. Braun, Matthew P.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  6. Breen, Philip

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

  7. Brightman, F. A.

    1. APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA
      F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
      Drug Metabolism and Disposition January 2006, 34 (1) 84-93; DOI: https://doi.org/10.1124/dmd.105.004804
    2. APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN HUMAN PLASMA
      F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
      Drug Metabolism and Disposition January 2006, 34 (1) 94-101; DOI: https://doi.org/10.1124/dmd.105.004838

  8. Brittebo, Eva B.

    1. CYP2A5-MEDIATED ACTIVATION AND EARLY ULTRASTRUCTURAL CHANGES IN THE OLFACTORY MUCOSA: STUDIES ON 2,6-DICHLOROPHENYL METHYLSULFONE
      Anna Franzén, Carina Carlsson, Veronica Hermansson, Matti Lang and Eva B. Brittebo
      Drug Metabolism and Disposition January 2006, 34 (1) 61-68; DOI: https://doi.org/10.1124/dmd.105.006221

  9. Brocks, Dion R.

    1. DETERMINATION OF THE ENZYME(S) INVOLVED IN THE METABOLISM OF AMIODARONE IN LIVER AND INTESTINE OF RAT: THE CONTRIBUTION OF CYTOCHROME P450 3A ISOFORMS
      Anooshirvan Shayeganpour, Ayman O. S. El-Kadi and Dion R. Brocks
      Drug Metabolism and Disposition January 2006, 34 (1) 43-50; DOI: https://doi.org/10.1124/dmd.105.006742

  10. Burt, Howard

    1. PREDICTION OF TIME-DEPENDENT CYP3A4 DRUG-DRUG INTERACTIONS: IMPACT OF ENZYME DEGRADATION, PARALLEL ELIMINATION PATHWAYS, AND INTESTINAL INHIBITION
      Aleksandra Galetin, Howard Burt, Laura Gibbons and J. Brian Houston
      Drug Metabolism and Disposition January 2006, 34 (1) 166-175; DOI: https://doi.org/10.1124/dmd.105.006874

C

  1. Carlsson, Carina

    1. CYP2A5-MEDIATED ACTIVATION AND EARLY ULTRASTRUCTURAL CHANGES IN THE OLFACTORY MUCOSA: STUDIES ON 2,6-DICHLOROPHENYL METHYLSULFONE
      Anna Franzén, Carina Carlsson, Veronica Hermansson, Matti Lang and Eva B. Brittebo
      Drug Metabolism and Disposition January 2006, 34 (1) 61-68; DOI: https://doi.org/10.1124/dmd.105.006221

  2. Carrier, Julie

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

  3. Cashman, John R.

    1. QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES
      Jun Zhang and John R. Cashman
      Drug Metabolism and Disposition January 2006, 34 (1) 19-26; DOI: https://doi.org/10.1124/dmd.105.006171

  4. Cheboyina, Sreekhar

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

  5. Chen, Qing

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  6. Cho, Taehyeon M.

    1. IN VITRO METABOLISM OF NAPHTHALENE BY HUMAN LIVER MICROSOMAL CYTOCHROME P450 ENZYMES
      Taehyeon M. Cho, Randy L. Rose and Ernest Hodgson
      Drug Metabolism and Disposition January 2006, 34 (1) 176-183; DOI: https://doi.org/10.1124/dmd.105.005785

  7. Coe, Jotham W.

    1. METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
      R. Scott Obach, Anne E. Reed-Hagen, Suzanne S. Krueger, Beth J. Obach, Thomas N. O'Connell, Kathleen S. Zandi, Sandra Miller and Jotham W. Coe
      Drug Metabolism and Disposition January 2006, 34 (1) 121-130; DOI: https://doi.org/10.1124/dmd.105.006767

  8. Cuthbertson, Alan

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

D

  1. Daidoji, Tomo

    1. SLOW ELIMINATION OF NONYLPHENOL FROM RAT INTESTINE
      Tomo Daidoji, Mihoko Ozawa, Hirokazu Sakamoto, Toshiro Sako, Hiroki Inoue, Ryo Kurihara, Shinya Hashimoto and Hiroshi Yokota
      Drug Metabolism and Disposition January 2006, 34 (1) 184-190; DOI: https://doi.org/10.1124/dmd.105.007229

  2. De La Cruz, Melanie

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  3. Diamond, Lauren

    1. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
      Joshua D. Lambert, Mao-Jung Lee, Lauren Diamond, Jihyeung Ju, Jungil Hong, Mousumi Bose, Harold L. Newmark and Chung S. Yang
      Drug Metabolism and Disposition January 2006, 34 (1) 8-11; DOI: https://doi.org/10.1124/dmd.104.003434

  4. Didolkar, Varsha

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  5. Dixit, Vaishali

    1. INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL
      Xu Guo, Vaishali Dixit, Huiping Liu, Albert L. Shroads, George N. Henderson, Margaret O. James and Peter W. Stacpoole
      Drug Metabolism and Disposition January 2006, 34 (1) 36-42; DOI: https://doi.org/10.1124/dmd.105.003996

  6. Doss, George A.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  7. du Souich, Patrick

    1. MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6
      Oksana Kourylko, Caroline Fradette, Mathieu Arcand and Patrick du Souich
      Drug Metabolism and Disposition January 2006, 34 (1) 27-35; DOI: https://doi.org/10.1124/dmd.105.006528

E

  1. El-Kadi, Ayman O. S.

    1. TRANSCRIPTIONAL REGULATION OF THE NAD(P)H:QUINONE OXIDOREDUCTASE 1 AND GLUTATHIONE S-TRANSFERASE YA GENES BY MERCURY, LEAD, AND COPPER
      Hesham M. Korashy and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition January 2006, 34 (1) 152-165; DOI: https://doi.org/10.1124/dmd.105.005397
    2. DETERMINATION OF THE ENZYME(S) INVOLVED IN THE METABOLISM OF AMIODARONE IN LIVER AND INTESTINE OF RAT: THE CONTRIBUTION OF CYTOCHROME P450 3A ISOFORMS
      Anooshirvan Shayeganpour, Ayman O. S. El-Kadi and Dion R. Brocks
      Drug Metabolism and Disposition January 2006, 34 (1) 43-50; DOI: https://doi.org/10.1124/dmd.105.006742

  2. Evans, David C.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

F

  1. Ferrin, Thomas E.

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  2. Fradette, Caroline

    1. MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6
      Oksana Kourylko, Caroline Fradette, Mathieu Arcand and Patrick du Souich
      Drug Metabolism and Disposition January 2006, 34 (1) 27-35; DOI: https://doi.org/10.1124/dmd.105.006528

  3. Franzén, Anna

    1. CYP2A5-MEDIATED ACTIVATION AND EARLY ULTRASTRUCTURAL CHANGES IN THE OLFACTORY MUCOSA: STUDIES ON 2,6-DICHLOROPHENYL METHYLSULFONE
      Anna Franzén, Carina Carlsson, Veronica Hermansson, Matti Lang and Eva B. Brittebo
      Drug Metabolism and Disposition January 2006, 34 (1) 61-68; DOI: https://doi.org/10.1124/dmd.105.006221

  4. Friisk, Grete Arneberg

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

G

  1. Gaedigk, Roger

    1. NUCLEAR RECEPTOR EXPRESSION IN FETAL AND PEDIATRIC LIVER: CORRELATION WITH CYP3A EXPRESSION
      Carrie A. Vyhlidal, Roger Gaedigk and J. Steven Leeder
      Drug Metabolism and Disposition January 2006, 34 (1) 131-137; DOI: https://doi.org/10.1124/dmd.105.005967

  2. Galetin, Aleksandra

    1. PREDICTION OF TIME-DEPENDENT CYP3A4 DRUG-DRUG INTERACTIONS: IMPACT OF ENZYME DEGRADATION, PARALLEL ELIMINATION PATHWAYS, AND INTESTINAL INHIBITION
      Aleksandra Galetin, Howard Burt, Laura Gibbons and J. Brian Houston
      Drug Metabolism and Disposition January 2006, 34 (1) 166-175; DOI: https://doi.org/10.1124/dmd.105.006874

  3. Giacomini, Kathleen M.

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  4. Gibbons, Laura

    1. PREDICTION OF TIME-DEPENDENT CYP3A4 DRUG-DRUG INTERACTIONS: IMPACT OF ENZYME DEGRADATION, PARALLEL ELIMINATION PATHWAYS, AND INTESTINAL INHIBITION
      Aleksandra Galetin, Howard Burt, Laura Gibbons and J. Brian Houston
      Drug Metabolism and Disposition January 2006, 34 (1) 166-175; DOI: https://doi.org/10.1124/dmd.105.006874

  5. Gibson, Gordon

    1. TRANSCRIPTIONAL REGULATION OF THE PXR GENE: IDENTIFICATION AND CHARACTERIZATION OF A FUNCTIONAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α BINDING SITE WITHIN THE PROXIMAL PROMOTER OF PXR
      Sihem Aouabdi, Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition January 2006, 34 (1) 138-144; DOI: https://doi.org/10.1124/dmd.105.006064

  6. Gipson, Amy E.

    1. GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
      Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
      Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

  7. Glaise, Denise

    1. EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
      Caroline Aninat, Amélie Piton, Denise Glaise, Typhen Le Charpentier, Sophie Langouët, Fabrice Morel, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition January 2006, 34 (1) 75-83; DOI: https://doi.org/10.1124/dmd.105.006759

  8. Glatt, Hansruedi

    1. STRUCTURAL ELUCIDATION OF HYDROXYLATED METABOLITES OF THE ISOFLAVAN EQUOL BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY
      Corinna E. Rüfer, Hansruedi Glatt and Sabine E. Kulling
      Drug Metabolism and Disposition January 2006, 34 (1) 51-60; DOI: https://doi.org/10.1124/dmd.105.004929

  9. Guguen-Guillouzo, Christiane

    1. EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
      Caroline Aninat, Amélie Piton, Denise Glaise, Typhen Le Charpentier, Sophie Langouët, Fabrice Morel, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition January 2006, 34 (1) 75-83; DOI: https://doi.org/10.1124/dmd.105.006759

  10. Guillouzo, André

    1. EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
      Caroline Aninat, Amélie Piton, Denise Glaise, Typhen Le Charpentier, Sophie Langouët, Fabrice Morel, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition January 2006, 34 (1) 75-83; DOI: https://doi.org/10.1124/dmd.105.006759

  11. Guo, Xu

    1. INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL
      Xu Guo, Vaishali Dixit, Huiping Liu, Albert L. Shroads, George N. Henderson, Margaret O. James and Peter W. Stacpoole
      Drug Metabolism and Disposition January 2006, 34 (1) 36-42; DOI: https://doi.org/10.1124/dmd.105.003996

  12. Gurley, Bill J.

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

H

  1. Hashimoto, Shinya

    1. SLOW ELIMINATION OF NONYLPHENOL FROM RAT INTESTINE
      Tomo Daidoji, Mihoko Ozawa, Hirokazu Sakamoto, Toshiro Sako, Hiroki Inoue, Ryo Kurihara, Shinya Hashimoto and Hiroshi Yokota
      Drug Metabolism and Disposition January 2006, 34 (1) 184-190; DOI: https://doi.org/10.1124/dmd.105.007229

  2. Henderson, George N.

    1. INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL
      Xu Guo, Vaishali Dixit, Huiping Liu, Albert L. Shroads, George N. Henderson, Margaret O. James and Peter W. Stacpoole
      Drug Metabolism and Disposition January 2006, 34 (1) 36-42; DOI: https://doi.org/10.1124/dmd.105.003996

  3. Hermansson, Veronica

    1. CYP2A5-MEDIATED ACTIVATION AND EARLY ULTRASTRUCTURAL CHANGES IN THE OLFACTORY MUCOSA: STUDIES ON 2,6-DICHLOROPHENYL METHYLSULFONE
      Anna Franzén, Carina Carlsson, Veronica Hermansson, Matti Lang and Eva B. Brittebo
      Drug Metabolism and Disposition January 2006, 34 (1) 61-68; DOI: https://doi.org/10.1124/dmd.105.006221

  4. Hodgson, Ernest

    1. IN VITRO METABOLISM OF NAPHTHALENE BY HUMAN LIVER MICROSOMAL CYTOCHROME P450 ENZYMES
      Taehyeon M. Cho, Randy L. Rose and Ernest Hodgson
      Drug Metabolism and Disposition January 2006, 34 (1) 176-183; DOI: https://doi.org/10.1124/dmd.105.005785

  5. Holsapple, Jeff

    1. GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
      Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
      Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

  6. Hong, Jungil

    1. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
      Joshua D. Lambert, Mao-Jung Lee, Lauren Diamond, Jihyeung Ju, Jungil Hong, Mousumi Bose, Harold L. Newmark and Chung S. Yang
      Drug Metabolism and Disposition January 2006, 34 (1) 8-11; DOI: https://doi.org/10.1124/dmd.104.003434

  7. Houston, J. Brian

    1. PREDICTION OF TIME-DEPENDENT CYP3A4 DRUG-DRUG INTERACTIONS: IMPACT OF ENZYME DEGRADATION, PARALLEL ELIMINATION PATHWAYS, AND INTESTINAL INHIBITION
      Aleksandra Galetin, Howard Burt, Laura Gibbons and J. Brian Houston
      Drug Metabolism and Disposition January 2006, 34 (1) 166-175; DOI: https://doi.org/10.1124/dmd.105.006874

  8. Huang, Conrad C.

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  9. Hubbard, Martha A.

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

  10. Hustvedt, Svein Olaf

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

I

  1. Inoue, Hiroki

    1. SLOW ELIMINATION OF NONYLPHENOL FROM RAT INTESTINE
      Tomo Daidoji, Mihoko Ozawa, Hirokazu Sakamoto, Toshiro Sako, Hiroki Inoue, Ryo Kurihara, Shinya Hashimoto and Hiroshi Yokota
      Drug Metabolism and Disposition January 2006, 34 (1) 184-190; DOI: https://doi.org/10.1124/dmd.105.007229

J

  1. Jacobsen, Petter Balke

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

  2. James, Margaret O.

    1. INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL
      Xu Guo, Vaishali Dixit, Huiping Liu, Albert L. Shroads, George N. Henderson, Margaret O. James and Peter W. Stacpoole
      Drug Metabolism and Disposition January 2006, 34 (1) 36-42; DOI: https://doi.org/10.1124/dmd.105.003996

  3. Johns, Susan J.

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  4. Ju, Jihyeung

    1. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
      Joshua D. Lambert, Mao-Jung Lee, Lauren Diamond, Jihyeung Ju, Jungil Hong, Mousumi Bose, Harold L. Newmark and Chung S. Yang
      Drug Metabolism and Disposition January 2006, 34 (1) 8-11; DOI: https://doi.org/10.1124/dmd.104.003434

K

  1. Kawamoto, Michiko

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  2. Korashy, Hesham M.

    1. TRANSCRIPTIONAL REGULATION OF THE NAD(P)H:QUINONE OXIDOREDUCTASE 1 AND GLUTATHIONE S-TRANSFERASE YA GENES BY MERCURY, LEAD, AND COPPER
      Hesham M. Korashy and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition January 2006, 34 (1) 152-165; DOI: https://doi.org/10.1124/dmd.105.005397

  3. Kourylko, Oksana

    1. MODULATION OF CYP1A2 AND CYP3A6 CATALYTIC ACTIVITIES BY SERUM FROM RABBITS WITH A TURPENTINE-INDUCED INFLAMMATORY REACTION AND INTERLEUKIN 6
      Oksana Kourylko, Caroline Fradette, Mathieu Arcand and Patrick du Souich
      Drug Metabolism and Disposition January 2006, 34 (1) 27-35; DOI: https://doi.org/10.1124/dmd.105.006528

  4. Krueger, Suzanne S.

    1. METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
      R. Scott Obach, Anne E. Reed-Hagen, Suzanne S. Krueger, Beth J. Obach, Thomas N. O'Connell, Kathleen S. Zandi, Sandra Miller and Jotham W. Coe
      Drug Metabolism and Disposition January 2006, 34 (1) 121-130; DOI: https://doi.org/10.1124/dmd.105.006767

  5. Kulling, Sabine E.

    1. STRUCTURAL ELUCIDATION OF HYDROXYLATED METABOLITES OF THE ISOFLAVAN EQUOL BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY
      Corinna E. Rüfer, Hansruedi Glatt and Sabine E. Kulling
      Drug Metabolism and Disposition January 2006, 34 (1) 51-60; DOI: https://doi.org/10.1124/dmd.105.004929

  6. Kurihara, Ryo

    1. SLOW ELIMINATION OF NONYLPHENOL FROM RAT INTESTINE
      Tomo Daidoji, Mihoko Ozawa, Hirokazu Sakamoto, Toshiro Sako, Hiroki Inoue, Ryo Kurihara, Shinya Hashimoto and Hiroshi Yokota
      Drug Metabolism and Disposition January 2006, 34 (1) 184-190; DOI: https://doi.org/10.1124/dmd.105.007229

L

  1. Lagpacan, Leah L.

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  2. Lambert, Joshua D.

    1. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
      Joshua D. Lambert, Mao-Jung Lee, Lauren Diamond, Jihyeung Ju, Jungil Hong, Mousumi Bose, Harold L. Newmark and Chung S. Yang
      Drug Metabolism and Disposition January 2006, 34 (1) 8-11; DOI: https://doi.org/10.1124/dmd.104.003434

  3. Lang, Matti

    1. CYP2A5-MEDIATED ACTIVATION AND EARLY ULTRASTRUCTURAL CHANGES IN THE OLFACTORY MUCOSA: STUDIES ON 2,6-DICHLOROPHENYL METHYLSULFONE
      Anna Franzén, Carina Carlsson, Veronica Hermansson, Matti Lang and Eva B. Brittebo
      Drug Metabolism and Disposition January 2006, 34 (1) 61-68; DOI: https://doi.org/10.1124/dmd.105.006221

  4. Langouët, Sophie

    1. EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
      Caroline Aninat, Amélie Piton, Denise Glaise, Typhen Le Charpentier, Sophie Langouët, Fabrice Morel, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition January 2006, 34 (1) 75-83; DOI: https://doi.org/10.1124/dmd.105.006759

  5. Langøy, Ann Svendsen

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

  6. Leahy, D. E.

    1. APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA
      F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
      Drug Metabolism and Disposition January 2006, 34 (1) 84-93; DOI: https://doi.org/10.1124/dmd.105.004804
    2. APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN HUMAN PLASMA
      F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
      Drug Metabolism and Disposition January 2006, 34 (1) 94-101; DOI: https://doi.org/10.1124/dmd.105.004838

  7. Le Charpentier, Typhen

    1. EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
      Caroline Aninat, Amélie Piton, Denise Glaise, Typhen Le Charpentier, Sophie Langouët, Fabrice Morel, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition January 2006, 34 (1) 75-83; DOI: https://doi.org/10.1124/dmd.105.006759

  8. Lee, Mao-Jung

    1. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
      Joshua D. Lambert, Mao-Jung Lee, Lauren Diamond, Jihyeung Ju, Jungil Hong, Mousumi Bose, Harold L. Newmark and Chung S. Yang
      Drug Metabolism and Disposition January 2006, 34 (1) 8-11; DOI: https://doi.org/10.1124/dmd.104.003434

  9. Leeder, J. Steven

    1. NUCLEAR RECEPTOR EXPRESSION IN FETAL AND PEDIATRIC LIVER: CORRELATION WITH CYP3A EXPRESSION
      Carrie A. Vyhlidal, Roger Gaedigk and J. Steven Leeder
      Drug Metabolism and Disposition January 2006, 34 (1) 131-137; DOI: https://doi.org/10.1124/dmd.105.005967

  10. Li, Chunze

    1. ACYL-COENZYME A FORMATION OF SIMVASTATIN IN MOUSE LIVER PREPARATIONS
      Chunze Li, Raju Subramanian, Sean Yu and Thomayant Prueksaritanont
      Drug Metabolism and Disposition January 2006, 34 (1) 102-110; DOI: https://doi.org/10.1124/dmd.105.006650

  11. Li, Wenying

    1. GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
      Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
      Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

  12. Liu, Huiping

    1. INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL
      Xu Guo, Vaishali Dixit, Huiping Liu, Albert L. Shroads, George N. Henderson, Margaret O. James and Peter W. Stacpoole
      Drug Metabolism and Disposition January 2006, 34 (1) 36-42; DOI: https://doi.org/10.1124/dmd.105.003996

  13. Liu, Wensheng

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

M

  1. Miller, Sandra

    1. METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
      R. Scott Obach, Anne E. Reed-Hagen, Suzanne S. Krueger, Beth J. Obach, Thomas N. O'Connell, Kathleen S. Zandi, Sandra Miller and Jotham W. Coe
      Drug Metabolism and Disposition January 2006, 34 (1) 121-130; DOI: https://doi.org/10.1124/dmd.105.006767

  2. Morel, Fabrice

    1. EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
      Caroline Aninat, Amélie Piton, Denise Glaise, Typhen Le Charpentier, Sophie Langouët, Fabrice Morel, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition January 2006, 34 (1) 75-83; DOI: https://doi.org/10.1124/dmd.105.006759

N

  1. Newmark, Harold L.

    1. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
      Joshua D. Lambert, Mao-Jung Lee, Lauren Diamond, Jihyeung Ju, Jungil Hong, Mousumi Bose, Harold L. Newmark and Chung S. Yang
      Drug Metabolism and Disposition January 2006, 34 (1) 8-11; DOI: https://doi.org/10.1124/dmd.104.003434

O

  1. O'Connell, Thomas N.

    1. METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
      R. Scott Obach, Anne E. Reed-Hagen, Suzanne S. Krueger, Beth J. Obach, Thomas N. O'Connell, Kathleen S. Zandi, Sandra Miller and Jotham W. Coe
      Drug Metabolism and Disposition January 2006, 34 (1) 121-130; DOI: https://doi.org/10.1124/dmd.105.006767

  2. Obach, Beth J.

    1. METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
      R. Scott Obach, Anne E. Reed-Hagen, Suzanne S. Krueger, Beth J. Obach, Thomas N. O'Connell, Kathleen S. Zandi, Sandra Miller and Jotham W. Coe
      Drug Metabolism and Disposition January 2006, 34 (1) 121-130; DOI: https://doi.org/10.1124/dmd.105.006767

  3. Obach, R. Scott

    1. METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
      R. Scott Obach, Anne E. Reed-Hagen, Suzanne S. Krueger, Beth J. Obach, Thomas N. O'Connell, Kathleen S. Zandi, Sandra Miller and Jotham W. Coe
      Drug Metabolism and Disposition January 2006, 34 (1) 121-130; DOI: https://doi.org/10.1124/dmd.105.006767

  4. Ogilvie, Brian W.

    1. GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
      Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
      Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

  5. Oulie, Inger

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

  6. Owen, Ryan P.

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  7. Ozawa, Mihoko

    1. SLOW ELIMINATION OF NONYLPHENOL FROM RAT INTESTINE
      Tomo Daidoji, Mihoko Ozawa, Hirokazu Sakamoto, Toshiro Sako, Hiroki Inoue, Ryo Kurihara, Shinya Hashimoto and Hiroshi Yokota
      Drug Metabolism and Disposition January 2006, 34 (1) 184-190; DOI: https://doi.org/10.1124/dmd.105.007229

P

  1. Parkinson, Andrew

    1. GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
      Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
      Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

  2. Piton, Amélie

    1. EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS
      Caroline Aninat, Amélie Piton, Denise Glaise, Typhen Le Charpentier, Sophie Langouët, Fabrice Morel, Christiane Guguen-Guillouzo and André Guillouzo
      Drug Metabolism and Disposition January 2006, 34 (1) 75-83; DOI: https://doi.org/10.1124/dmd.105.006759

  3. Plant, Nick

    1. TRANSCRIPTIONAL REGULATION OF THE PXR GENE: IDENTIFICATION AND CHARACTERIZATION OF A FUNCTIONAL PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α BINDING SITE WITHIN THE PROXIMAL PROMOTER OF PXR
      Sihem Aouabdi, Gordon Gibson and Nick Plant
      Drug Metabolism and Disposition January 2006, 34 (1) 138-144; DOI: https://doi.org/10.1124/dmd.105.006064

  4. Prueksaritanont, Thomayant

    1. ACYL-COENZYME A FORMATION OF SIMVASTATIN IN MOUSE LIVER PREPARATIONS
      Chunze Li, Raju Subramanian, Sean Yu and Thomayant Prueksaritanont
      Drug Metabolism and Disposition January 2006, 34 (1) 102-110; DOI: https://doi.org/10.1124/dmd.105.006650

R

  1. Reed-Hagen, Anne E.

    1. METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
      R. Scott Obach, Anne E. Reed-Hagen, Suzanne S. Krueger, Beth J. Obach, Thomas N. O'Connell, Kathleen S. Zandi, Sandra Miller and Jotham W. Coe
      Drug Metabolism and Disposition January 2006, 34 (1) 121-130; DOI: https://doi.org/10.1124/dmd.105.006767

  2. Rodrigues, A. David

    1. GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
      Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
      Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

  3. Rose, Randy L.

    1. IN VITRO METABOLISM OF NAPHTHALENE BY HUMAN LIVER MICROSOMAL CYTOCHROME P450 ENZYMES
      Taehyeon M. Cho, Randy L. Rose and Ernest Hodgson
      Drug Metabolism and Disposition January 2006, 34 (1) 176-183; DOI: https://doi.org/10.1124/dmd.105.005785

  4. Roychowdhury, Sanjoy

    1. ROLE OF HUMAN CYCLOOXYGENASE-2 IN THE BIOACTIVATION OF DAPSONE AND SULFAMETHOXAZOLE
      Piyush M. Vyas, Sanjoy Roychowdhury and Craig K. Svensson
      Drug Metabolism and Disposition January 2006, 34 (1) 16-18; DOI: https://doi.org/10.1124/dmd.105.006890

  5. Rüfer, Corinna E.

    1. STRUCTURAL ELUCIDATION OF HYDROXYLATED METABOLITES OF THE ISOFLAVAN EQUOL BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY
      Corinna E. Rüfer, Hansruedi Glatt and Sabine E. Kulling
      Drug Metabolism and Disposition January 2006, 34 (1) 51-60; DOI: https://doi.org/10.1124/dmd.105.004929

S

  1. Sakamoto, Hirokazu

    1. SLOW ELIMINATION OF NONYLPHENOL FROM RAT INTESTINE
      Tomo Daidoji, Mihoko Ozawa, Hirokazu Sakamoto, Toshiro Sako, Hiroki Inoue, Ryo Kurihara, Shinya Hashimoto and Hiroshi Yokota
      Drug Metabolism and Disposition January 2006, 34 (1) 184-190; DOI: https://doi.org/10.1124/dmd.105.007229

  2. Sako, Toshiro

    1. SLOW ELIMINATION OF NONYLPHENOL FROM RAT INTESTINE
      Tomo Daidoji, Mihoko Ozawa, Hirokazu Sakamoto, Toshiro Sako, Hiroki Inoue, Ryo Kurihara, Shinya Hashimoto and Hiroshi Yokota
      Drug Metabolism and Disposition January 2006, 34 (1) 184-190; DOI: https://doi.org/10.1124/dmd.105.007229

  3. Sandosham, Jessie

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

  4. Searle, G. E.

    1. APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA
      F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
      Drug Metabolism and Disposition January 2006, 34 (1) 84-93; DOI: https://doi.org/10.1124/dmd.105.004804
    2. APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN HUMAN PLASMA
      F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
      Drug Metabolism and Disposition January 2006, 34 (1) 94-101; DOI: https://doi.org/10.1124/dmd.105.004838

  5. Shayeganpour, Anooshirvan

    1. DETERMINATION OF THE ENZYME(S) INVOLVED IN THE METABOLISM OF AMIODARONE IN LIVER AND INTESTINE OF RAT: THE CONTRIBUTION OF CYTOCHROME P450 3A ISOFORMS
      Anooshirvan Shayeganpour, Ayman O. S. El-Kadi and Dion R. Brocks
      Drug Metabolism and Disposition January 2006, 34 (1) 43-50; DOI: https://doi.org/10.1124/dmd.105.006742

  6. Shroads, Albert L.

    1. INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL
      Xu Guo, Vaishali Dixit, Huiping Liu, Albert L. Shroads, George N. Henderson, Margaret O. James and Peter W. Stacpoole
      Drug Metabolism and Disposition January 2006, 34 (1) 36-42; DOI: https://doi.org/10.1124/dmd.105.003996

  7. Skotland, Tore

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

  8. Song, Peng-fei

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

  9. Stacpoole, Peter W.

    1. INHIBITION AND RECOVERY OF RAT HEPATIC GLUTATHIONE S-TRANSFERASE ZETA AND ALTERATION OF TYROSINE METABOLISM FOLLOWING DICHLOROACETATE EXPOSURE AND WITHDRAWAL
      Xu Guo, Vaishali Dixit, Huiping Liu, Albert L. Shroads, George N. Henderson, Margaret O. James and Peter W. Stacpoole
      Drug Metabolism and Disposition January 2006, 34 (1) 36-42; DOI: https://doi.org/10.1124/dmd.105.003996

  10. Stearns, Ralph A.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  11. Strauss, John R.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  12. Stryke, Doug

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  13. Subramanian, Raju

    1. ACYL-COENZYME A FORMATION OF SIMVASTATIN IN MOUSE LIVER PREPARATIONS
      Chunze Li, Raju Subramanian, Sean Yu and Thomayant Prueksaritanont
      Drug Metabolism and Disposition January 2006, 34 (1) 102-110; DOI: https://doi.org/10.1124/dmd.105.006650

  14. Svensson, Craig K.

    1. ROLE OF HUMAN CYCLOOXYGENASE-2 IN THE BIOACTIVATION OF DAPSONE AND SULFAMETHOXAZOLE
      Piyush M. Vyas, Sanjoy Roychowdhury and Craig K. Svensson
      Drug Metabolism and Disposition January 2006, 34 (1) 16-18; DOI: https://doi.org/10.1124/dmd.105.006890

T

  1. Tang, Wei

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  2. Tang, Yui S.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  3. Taylor, Travis R.

    1. FUNCTIONAL CHARACTERIZATION AND HAPLOTYPE ANALYSIS OF POLYMORPHISMS IN THE HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER, ENT2
      Ryan P. Owen, Leah L. Lagpacan, Travis R. Taylor, Melanie De La Cruz, Conrad C. Huang, Michiko Kawamoto, Susan J. Johns, Doug Stryke, Thomas E. Ferrin and Kathleen M. Giacomini
      Drug Metabolism and Disposition January 2006, 34 (1) 12-15; DOI: https://doi.org/10.1124/dmd.105.006270

  4. Thomas, S.

    1. APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN RAT PLASMA
      F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
      Drug Metabolism and Disposition January 2006, 34 (1) 84-93; DOI: https://doi.org/10.1124/dmd.105.004804
    2. APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN HUMAN PLASMA
      F. A. Brightman, D. E. Leahy, G. E. Searle and S. Thomas
      Drug Metabolism and Disposition January 2006, 34 (1) 94-101; DOI: https://doi.org/10.1124/dmd.105.004838

  5. Toft, Kim Gunnar

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

  6. Tong, Yudong

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

  7. Toren, Paul

    1. GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
      Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
      Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

  8. Tung, Elaine C.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

U

  1. Uran, Steinar

    1. NC100668, A NEW TRACER FOR IMAGING OF VENOUS THROMBOEMBOLISM: DISPOSITION AND METABOLISM IN RATS
      Tore Skotland, Svein Olaf Hustvedt, Inger Oulie, Petter Balke Jacobsen, Grete Arneberg Friisk, Ann Svendsen Langøy, Steinar Uran, Jessie Sandosham, Alan Cuthbertson and Kim Gunnar Toft
      Drug Metabolism and Disposition January 2006, 34 (1) 111-120; DOI: https://doi.org/10.1124/dmd.105.006239

V

  1. Vyas, Piyush M.

    1. ROLE OF HUMAN CYCLOOXYGENASE-2 IN THE BIOACTIVATION OF DAPSONE AND SULFAMETHOXAZOLE
      Piyush M. Vyas, Sanjoy Roychowdhury and Craig K. Svensson
      Drug Metabolism and Disposition January 2006, 34 (1) 16-18; DOI: https://doi.org/10.1124/dmd.105.006890

  2. Vyhlidal, Carrie A.

    1. NUCLEAR RECEPTOR EXPRESSION IN FETAL AND PEDIATRIC LIVER: CORRELATION WITH CYP3A EXPRESSION
      Carrie A. Vyhlidal, Roger Gaedigk and J. Steven Leeder
      Drug Metabolism and Disposition January 2006, 34 (1) 131-137; DOI: https://doi.org/10.1124/dmd.105.005967

W

  1. Wang, Regina W.

    1. EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS
      Qing Chen, George A. Doss, Elaine C. Tung, Wensheng Liu, Yui S. Tang, Matthew P. Braun, Varsha Didolkar, John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie and Wei Tang
      Drug Metabolism and Disposition January 2006, 34 (1) 145-151; DOI: https://doi.org/10.1124/dmd.105.004341

  2. Williams, D. Keith

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

Y

  1. Yang, Chung S.

    1. DOSE-DEPENDENT LEVELS OF EPIGALLOCATECHIN-3-GALLATE IN HUMAN COLON CANCER CELLS AND MOUSE PLASMA AND TISSUES
      Joshua D. Lambert, Mao-Jung Lee, Lauren Diamond, Jihyeung Ju, Jungil Hong, Mousumi Bose, Harold L. Newmark and Chung S. Yang
      Drug Metabolism and Disposition January 2006, 34 (1) 8-11; DOI: https://doi.org/10.1124/dmd.104.003434

  2. Yates, C. Ryan

    1. EFFECT OF MILK THISTLE (SILYBUM MARIANUM) AND BLACK COHOSH (CIMICIFUGA RACEMOSA) SUPPLEMENTATION ON DIGOXIN PHARMACOKINETICS IN HUMANS
      Bill J. Gurley, Gary W. Barone, D. Keith Williams, Julie Carrier, Philip Breen, C. Ryan Yates, Peng-fei Song, Martha A. Hubbard, Yudong Tong and Sreekhar Cheboyina
      Drug Metabolism and Disposition January 2006, 34 (1) 69-74; DOI: https://doi.org/10.1124/dmd.105.006312

  3. Yokota, Hiroshi

    1. SLOW ELIMINATION OF NONYLPHENOL FROM RAT INTESTINE
      Tomo Daidoji, Mihoko Ozawa, Hirokazu Sakamoto, Toshiro Sako, Hiroki Inoue, Ryo Kurihara, Shinya Hashimoto and Hiroshi Yokota
      Drug Metabolism and Disposition January 2006, 34 (1) 184-190; DOI: https://doi.org/10.1124/dmd.105.007229

  4. Yu, Sean

    1. ACYL-COENZYME A FORMATION OF SIMVASTATIN IN MOUSE LIVER PREPARATIONS
      Chunze Li, Raju Subramanian, Sean Yu and Thomayant Prueksaritanont
      Drug Metabolism and Disposition January 2006, 34 (1) 102-110; DOI: https://doi.org/10.1124/dmd.105.006650

Z

  1. Zandi, Kathleen S.

    1. METABOLISM AND DISPOSITION OF VARENICLINE, A SELECTIVE α4β2 ACETYLCHOLINE RECEPTOR PARTIAL AGONIST, IN VIVO AND IN VITRO
      R. Scott Obach, Anne E. Reed-Hagen, Suzanne S. Krueger, Beth J. Obach, Thomas N. O'Connell, Kathleen S. Zandi, Sandra Miller and Jotham W. Coe
      Drug Metabolism and Disposition January 2006, 34 (1) 121-130; DOI: https://doi.org/10.1124/dmd.105.006767

  2. Zhang, Donglu

    1. GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS
      Brian W. Ogilvie, Donglu Zhang, Wenying Li, A. David Rodrigues, Amy E. Gipson, Jeff Holsapple, Paul Toren and Andrew Parkinson
      Drug Metabolism and Disposition January 2006, 34 (1) 191-197; DOI: https://doi.org/10.1124/dmd.105.007633

  3. Zhang, Jun

    1. QUANTITATIVE ANALYSIS OF FMO GENE mRNA LEVELS IN HUMAN TISSUES
      Jun Zhang and John R. Cashman
      Drug Metabolism and Disposition January 2006, 34 (1) 19-26; DOI: https://doi.org/10.1124/dmd.105.006171
Back to top

In this issue